In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Celsion Corp (NASDAQ:CLSN) reported that Anson Funds Management Lp has picked up 760,000 of common stock as of 2017-07-17.
The acquisition brings the aggregate amount owned by Anson Funds Management Lp to a total of 760,000 representing a 9.6% in the company.
For those not familiar with the company, Celsion Corporation is an oncology drug development company. The Company’s product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
A glance at Celsion Corp (NASDAQ:CLSN)s key stats reveals a current market capitalization of 7.74 Million based on 4.07 Million shares outstanding and a price at last close of $1.86 Per Share.
Looking at insider activity, there are a few recent transactions worth noting.
Specifically, on 2017-07-07, Fritz picked up 6,500 at a purchase price of $1.90. This brings their total holding to 6,500 as of the date of the filing.
On the sell side, the most recent transaction saw Egwu, unload 5,556 shares at a sale price of $2.08. This brings their total holding to 2,421,867.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Celsion Corp (NASDAQ:CLSN) as things move forward to see if its progress aligns with these transactions. Subscribe below and we’ll keep you on top of what’s happening before it moves markets.